PET/CT Doctors Abroad — Page 2

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Professor Onder Surgit is a senior surgeon at Optimed International Hospital. He uses PET/CT imaging to guide complex cancer surgeries and laparoscopic procedures.

• Holds the academic title of Professor of Medicine
• Specializes in cancer surgery and advanced laparoscopic techniques
• Served as an instructor surgeon at the Advanced Medical Technologies Training Center
• Former faculty member at Turgut Ozal University Faculty of Medicine
• Graduate of the prestigious Hacettepe Faculty of Medicine

Dr. Zhang Yanjun is a Chief Physician at Jinshazhou Hospital who specializes in tumor imaging and radiation oncology. She brings senior clinical expertise to PET/CT diagnostics for complex cancer cases.

• Trained as a visiting scholar at two top-tier radiation therapy hospitals in the United States
• Published 46 academic papers on tumor diagnosis in international medical journals
• Member of the Central Nervous System Tumor Radiotherapy Group for the Chinese Medical Doctor Association
• Expert in identifying primary and secondary tumors in both children and adult patients

Professor Ido Nachmany is a Forbes-recognized top physician at Sheba Medical Center. He heads the general surgery department and specializes in complex tumor diagnostics including PET/CT scans.

• Expert in gastrointestinal neuroendocrine tumors – rare cancers requiring precise PET/CT staging
• Fellowship trained at the Thomas E. Starzl Transplantation Institute in the USA
• Senior Lecturer at Tel Aviv University faculty of medicine
• Member of the International Hepato-Pancreato-Biliary Association
• Published researcher in surgical oncology and medical imaging for cancer detection

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Dr. Almog Ben Yaacov is a senior oncological surgeon at Sheba Medical Center. He completed advanced surgical oncology training at Memorial Sloan Kettering Cancer Center in New York.

• Specializes in complex abdominal cancers where PET/CT is vital for surgical planning
• Trained in NanoKnife technology at King’s College London for treating difficult tumors
• Performed over 200 HIPEC procedures to treat advanced abdominal wall metastases
• Graduated with honors and holds board certifications in both general and surgical oncology

Dr. Antonio Alcaraz is a lead uro-oncologist at Hospital Quiron Barcelona. He specializes in the surgical treatment of prostate, bladder, and kidney cancers often detected via PET/CT scans.

• Performed over 500 successful operations for urogenital pathologies.
• World first surgeon to perform transvaginal NOTES nephrectomy through natural body openings.
• Heads the Urology Department at Teknon Medical Center in Barcelona.
• Uses the Da Vinci robotic system for high-precision tumor removals.
• Holds a Hirsch index of 27 reflecting significant contributions to medical research.

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Sefik Igdem is a radiation oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating head, neck, and prostate cancers. He currently serves as a Professor at Demiroğlu Bilim University. Dr. Igdem uses Truebeam STx and Halcyon systems for accurate radiotherapy.

• Specializes in conformal treatments for complex tumor cases.
• Treats various conditions including lung, breast, and brain tumors.
• Practices at a JCI-accredited hospital that serves 200,000 patients annually.
• Completed his radiation oncology training at the Istanbul University Cerrahpaşa Faculty.

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Dr. David Kuczer is a specialist in radio-oncology and radiotherapy. He leads cancer diagnostics at Amethyst Radiotherapy at the Vienna Private Clinic.

• Coordinates cases with an interdisciplinary tumor board for expert review
• Specializes in using PET/CT for precise cancer diagnosis and treatment planning
• Member of the Cancer Center of the Vienna Private Clinic
• Provides rapid access to imaging results according to scientific standards
• Works with an internationally recognized team of oncology experts

Professor Amit Tirosh leads the neuroendocrine tumor service at Sheba Medical Center. He specializes in using PET/CT scans to track and treat complex endocrine cancers.

• Trained in neuroendocrine tumors at the National Institutes of Health in the USA
• Provides peptide receptor radionuclide therapy – a targeted treatment for advanced cancer cases
• Expert panelist for international VHL disease guidelines – a rare genetic cancer syndrome
• Published research on Gallium-68 DOTATATE – a specialized radioactive tracer for neuroendocrine PET/CT
• Member of the European Neuroendocrine Tumors Society

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Jaume Mora Graupera leads pediatric oncology at SJD Barcelona Children’s Hospital. He specialized in pediatric cancer at Memorial Sloan Kettering Cancer Center.

• Coordinates oncologic imaging including PET/CT for pediatric sarcomas and brain tumors
• Scientific Director of the Hematology Oncology Department in Barcelona
• Developed non-radiative treatments to protect the developing nervous systems of children
• Authored over 70 scientific papers investigating advanced childhood cancer treatments
• Awarded the Schweisguth Prize by the International Society of Pediatric Oncology

Dr. Sinan Karaaslan is a Doctor of Medical Sciences at Anadolu Medical Center. He uses detailed PET/CT results to plan systemic therapies for complex cancer cases.

• Specializes in stage 4 lung and colon cancer treatments
• Member of the Turkish Lung Cancer Society
• Trained at Istanbul University – one of Turkey's top medical schools
• Expert in targeted therapy and immunotherapy for advanced malignancies
• Former oncology expert at the Gülhane Military Medical Academy

Professor Yesim Yildirim is an ESMO-certified medical oncologist at Anadolu Medical Center. She uses PET/CT imaging to manage breast, lung, and gastrointestinal cancers.

• Completed advanced oncology training at Rambam Medical Center in Israel
• Specialized in immunooncology at Mount Vernon Cancer Center in the UK
• Authored over 80 scientific works on precision medicine and cancer care
• Founded the Turkish Gastrointestinal Oncology Network to improve specialist collaboration
• Member of the American Society of Clinical Oncology (ASCO)

Professor Seref Komurcu is an ESMO-certified oncologist at Anadolu Medical Center. He utilizes PET/CT imaging to guide systemic therapies for various solid tumors.

• Authored over 110 scientific papers on cancer treatment protocols
• Certified by the European Society for Medical Oncology (ESMO)
• Held a professorship at the Gülhane Military Medical Academy for years
• Specializes in using targeted therapies and immunotherapy for lung and breast cancers
• Active member of the American Society of Clinical Oncology (ASCO)

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.